Pfizer CEO ‘disappointed’ by Robert Kennedy’s refusal to rebut claims on vaccine risks
Pfizer’s chief executive said he was “disappointed” with Robert F Kennedy Jr’s refusal to disavow the debunked link between vaccines and autism, even as he expressed confidence that the Trump administration would avoid stoking a health crisis.
1don MSN
Pfizer shares were rising early Tuesday after the company reported fourth-quarter earnings and revenue that came in ahead of ...
Unexpected demand for Pfizer Inc.’s Covid vaccine helped the company beat quarterly expectations. Then Robert F. Kennedy Jr., ...
Pfizer CEO has met with the new administration and believes Trump and RFK Jr. are going to be net positives for the health ...
Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
Pfizer Inc. (NYSE: PFE) shares are trading lower Tuesday after the Senate Finance Committee voted to advance Robert F. Kennedy Jr.'s nomination for Secretary of Health and Human Services.
Kennedy, who has faced opposition from health groups and Democrats, has long sown doubts about the safety and efficacy of ...
Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback